Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Sanofi-Aventis acquires exclusive global rights to CureDM's Pancreate

CureDM, LLC announced today that an agreement has been signed with Sanofi-Aventis for the exclusive worldwide license of Pancreate™, a novel islet neogenesis agent for the treatment of type 1 and type 2 diabetes. CureDM is a privately held biopharmaceutical company whose scientists discovered Pancreate™, a first-in-class human peptide therapeutic. Several key Composition of Matter and Use patents have been issued to CureDM for this potentially transforming treatment approach for diabetes.

9 Apr 2010

Pittsburgh managing diabetes more cost effectively than other states

Pittsburgh is treating diabetes more cost effectively than the rest of the state and nation, and its efforts to help people better manage their disease are paying dividends. Still, a gap exists between the region and the nation's top performers, according to the third annual Pittsburgh Business Group on Health Type 2 Diabetes Report.

8 Apr 2010

Meltdown Station provides educational material to help children learn healthy lifestyle skills

With the childhood obesity epidemic finally at the front line, first lady Mrs. Obama has taken the initiative to do something about it, but what is she doing? The first lady Mrs. Obama started the Let's Move! Initiative and stated in a press conference "that the goal of the program is to reverse the trend toward childhood obesity in one generation."

8 Apr 2010

Americans are getting heavier younger and carrying extra weight for longer periods: Study

It was a provocative prediction that due to the obesity epidemic Baby Boomers may outlive their children.

8 Apr 2010

OSU-CG12 agent kills cancer cells through energy restriction: Study

Cancer cells grow so fast that they can outstrip their blood supply, leaving them short of oxygen. The cells then produce energy in a way that needs less oxygen but more sugar.

8 Apr 2010

Adherence to type 1 diabetes treatment lags if parents don't monitor

Teenagers and "tweenagers" with type 1 diabetes have more trouble sticking to their treatment plan - thus raising their risk of blindness, kidney failure and heart disease - if their parents become increasingly lax about monitoring the child's treatment, or if the mother-child relationship is poor.

8 Apr 2010

Researchers discover two genetic regions that influence birth weight

New research uncovers two genetic regions that influence birth weight. One of the regions is also associated with type 2 diabetes, which helps to explain why small babies have higher rates of diabetes in later life.

8 Apr 2010

Updates from Phase I/IIa clinical trial of DIABECELL treatment in insulin-dependent diabetics

Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, today provided a penultimate update regarding the three-year follow up of its Phase I/IIa clinical trial in Russia of its DIABECELL® treatment in insulin-dependent diabetics.

7 Apr 2010

Obstacles in urban setting limits physical activity and promotes unhealthy food consumption

The conditions of urban environments have been linked to an escalation of noncommunicable diseases such as Type II diabetes, obesity, hypertension, and cardiovascular disease. These diseases are preventable and manageable through exercise, which is why the International Sports Sciences Association (ISSA) is dedicated to stemming the tide of poor health and physical decline by providing distance fitness education to health and fitness professionals, as well as other interested individuals.

7 Apr 2010

Soccer for Health

Led by Professors Peter Krustrup and Jens Bangsbo from the Department of Exercise and Sports Sciences, University of Copenhagen, the 3-year project covered several intervention studies involving both men, women and children, who were divided into soccer, running and control groups.

7 Apr 2010

IPS examines malnutrition, obesity in Latin America

Inter Press Service examines malnutrition and factors contributing to the rising rates of "obesity and obesity-related illness - such as type II diabetes, high blood pressure, heart disease, some forms of cancer and osteoporosis - in Latin America, and especially among the poorest sectors of the population."

7 Apr 2010

International experts recommend individualized treatment for type 2 diabetic patients

Patients with type 2 diabetes are generally treated similarly despite the fact that they may have underlying differences that could affect their therapeutic response.

6 Apr 2010

Alpha cells in pancreas can convert into insulin-producing beta cells: Study

Alpha cells in the pancreas, which do not produce insulin, can convert into insulin-producing beta cells, advancing the prospect of regenerating beta cells as a cure for type 1 diabetes. The findings come from a study at the University of Geneva, co-funded by the Juvenile Diabetes Research Foundation, that is published today in the online edition of the scientific journal Nature.

6 Apr 2010

Individualized therapies for treating type 2 diabetes recommended

Chevy Chase, MD-Patients with type 2 diabetes are generally treated similarly despite the fact that they may have underlying differences that could affect their therapeutic response. Seeking to address this critical health issue, an international multidisciplinary group of experts just issued recommendations for individualized treatment in a consensus statement to be published in the April 2010 issue of the Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

5 Apr 2010

Diabetic tests must be regulated

As a benchmark for diagnosing diabetes, the importance of the A1C test must be reevaluated to improve glycemic numeracy of policy makers, patients and providers – who must make real-world decisions. This is based on a commentary published by Wiley-Blackwell in the Journal of Diabetes.

5 Apr 2010

DNA resources coupled to EMR systems hold potential as valuable tools for clinical research

A new study reveals an exciting potential benefit of the rapidly accumulating databases of health care information, the ability to make unprecedented links between genomic data and clinical medicine. The research, published by Cell Press in the April issue of the American Journal of Human Genetics, supports the idea that large scale DNA databanks linked to electronic medical record (EMR) systems provide a valuable platform for discovering, assessing and validating associations between genes and diseases.

2 Apr 2010

Study finds potential role of NGF in islet transplantation

Islet transplantation is a promising treatment for type 1 diabetes mellitus. The promotion of angiogenesis is an important endeavor to prevent islet graft failure. Endothelial precursor cells (EPCs), a heterogeneous group originating in the hematopoietic compartment of bone marrow, have an important role in the angiogenesis of adult tissues.

2 Apr 2010

Mayo Clinic introduces a reliable and easy-to-understand resource on alternative medicine

Want to find ways that may help prevent illness naturally, for a fraction of the cost of a trip to the doctor? Interested in taking control of your health with evidence-based practices that complement conventional medicine?

2 Apr 2010

Schering-Plough HealthCare Products commences promotion of ZEGERID OTC in North America

Santarus, Inc., a specialty biopharmaceutical company, today announced that Schering-Plough HealthCare Products, Inc., the consumer healthcare subsidiary of Merck & Co., Inc., has commenced promotion of ZEGERID OTC™ (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules) under its licensing agreement with Santarus for the over-the-counter (OTC) market in North America. The OTC heartburn market in the U.S. is estimated at approximately $1.8 billion based on data from market research firm Information Resources, Inc. and Santarus estimates.

2 Apr 2010

Radio show on ways to reduce sugar intake and live healthier

Monday, April 5th at 7pm EDT (4pm PDT) on the Telonauts Hour Radio Show Dr. Jacob Teitelbaum MD, author of Beat Sugar Addiction Now, will join longevity expert Dr. Dave Woynarowski MD and fitness pioneer Greta Blackburn, both of Telonauts.com, to discuss ways people can reduce their sugar intakes and live healthier, less sugar-addicted lives.

1 Apr 2010

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Sanofi-Aventis acquires exclusive global rights to CureDM's Pancreate

Pittsburgh managing diabetes more cost effectively than other states

Meltdown Station provides educational material to help children learn healthy lifestyle skills

Americans are getting heavier younger and carrying extra weight for longer periods: Study

OSU-CG12 agent kills cancer cells through energy restriction: Study

Adherence to type 1 diabetes treatment lags if parents don't monitor

Researchers discover two genetic regions that influence birth weight

Updates from Phase I/IIa clinical trial of DIABECELL treatment in insulin-dependent diabetics

Obstacles in urban setting limits physical activity and promotes unhealthy food consumption

Soccer for Health

IPS examines malnutrition, obesity in Latin America

International experts recommend individualized treatment for type 2 diabetic patients

Alpha cells in pancreas can convert into insulin-producing beta cells: Study

Individualized therapies for treating type 2 diabetes recommended

Diabetic tests must be regulated

DNA resources coupled to EMR systems hold potential as valuable tools for clinical research

Study finds potential role of NGF in islet transplantation

Mayo Clinic introduces a reliable and easy-to-understand resource on alternative medicine

Schering-Plough HealthCare Products commences promotion of ZEGERID OTC in North America

Radio show on ways to reduce sugar intake and live healthier

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in